Opolskie centrum Onkologii
Opole 45-061
2 studies enrolling now · 8 studies all time
What they study most
Breast Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Gastroesophageal Junction Adenocarcinoma, HER2-positive Breast Cancer, Locally Advanced or Metastatic Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma, Refractory Metastatic Gastric Cancer, Venous Thromboembolism
Studies at this site
- A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
- A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
- RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) — Running, not enrolling
- A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
- A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC) — Stopped early
- Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer — Completed
- Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed